Rock Springs Capital Management’s Immunocore IMCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-419,030
Closed -$14.2M 115
2024
Q2
$14.2M Sell
419,030
-1,948,786
-82% -$99.4M 0.43% 59
2024
Q1
$154M Sell
2,367,816
-293,691
-11% -$20.2M 3.91% 2
2023
Q4
$182M Sell
2,661,507
-282,203
-10% -$14.7M 4.49% 2
2023
Q3
$153M Sell
2,943,710
-84,700
-3% -$5.01M 4.09% 2
2023
Q2
$182M Buy
3,028,410
+26,748
+0.9% +$1.53M 4.32% 2
2023
Q1
$148M Sell
3,001,662
-319,404
-10% -$18M 3.54% 4
2022
Q4
$190M Sell
3,321,066
-172,677
-5% -$9.72M 4.56% 2
2022
Q3
$164M Buy
3,493,743
+822,091
+31% +$39.2M 4.24% 3
2022
Q2
$99.7M Buy
2,671,652
+119,618
+5% +$3.89M 2.9% 7
2022
Q1
$76.3M Buy
2,552,034
+80,479
+3% +$2.03M 1.92% 15
2021
Q4
$84.6M Buy
2,471,555
+26,400
+1% +$956K 1.96% 13
2021
Q3
$90.6M Buy
2,445,155
+50,370
+2% +$1.7M 1.91% 14
2021
Q2
$93.5M Buy
2,394,785
+102,500
+4% +$3.96M 1.85% 13
2021
Q1
$97.6M Buy
+2,292,285
New +$102M 2.13% 8

Other funds holding IMCR